Pulse Biosciences shares surge 2.34% afterhours due to rights offering closure with oversubscription and $83M raised.

Pulse Biosciences, Inc. experienced a 2.34% increase in after-hours trading following the announcement of the successful closing of its rights offering. The company raised approximately $83 million, exceeding the $60 million target by 138%, indicating strong investor support. This positive development, with participation from over 800 accounts, including Executive Chairman Robert Duggan, contributed to the stock's uplift during the after-hours session. The rights offering's success demonstrates the confidence in Pulse Biosciences' CellFX® Nanosecond Pulsed Field Ablation™ technology and its potential for growth.